Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05039801
Title IACS-6274 With or Without Pembrolizumab for the Treatment of Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

head and neck squamous cell carcinoma

endometrial cancer

ovarian serous carcinoma

melanoma

ovarian clear cell carcinoma

Advanced Solid Tumor

chondrosarcoma

Therapies

IPN60090

IPN60090 + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.